Tirzepatide 10mg is a novel dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This lyophilized white powder demonstrates 99% purity and is supplied in sterile vials for research applications.
As a dual incretin mimetic, tirzepatide 10mg combines the metabolic benefits of both GLP-1 and GIP pathways. Research indicates significant potential in glucose regulation and weight management applications. The compound has shown superior efficacy compared to single-pathway agonists in clinical studies.
Key research applications of tirzepatide 10mg include: pancreatic beta cell function studies, gastric emptying research, appetite regulation mechanisms, and metabolic syndrome investigations. The PEG-modified structure enhances water solubility while maintaining biological activity.
Our tirzepatide 10mg is manufactured under strict GMP conditions with comprehensive quality control. Each batch undergoes rigorous HPLC and mass spectrometry analysis to ensure purity and consistency. The lyophilized form ensures excellent stability for research purposes.
Storage recommendations: Maintain tirzepatide 10mg vials at -20°C in dry conditions. For reconstitution, use sterile water or saline solution. Proper handling procedures should be followed for all research applications.
Note: This product is intended for research use only. Not for human consumption. Researchers should consult all applicable regulations before ordering tirzepatide 10mg for laboratory studies.